Joseph L. Turner Insider Profile
4 Followers
Joseph L. Turner, Director at Arcutis Biotherapeutics, holds 4.31K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 10.50K shares in Alexza Pharmaceuticals (Ticker: ALXA), holds 0.00 shares in Kythera (Ticker: KYTH).
Joseph L. Turner's Trading History
| ARQTArcutis Biotherapeutics | Jun 03, 2022 | Director | Uninformative Buy | ― | $117.07K | |
| ALXAAlexza Pharmaceuticals | Jun 21, 2016 | ― | Uninformative Sell | ― | $9.82K | |
| KYTHKythera | Oct 02, 2015 | ― | Uninformative Sell | ― | $0.00 | |
| CORTCorcept Therapeutics | Mar 14, 2013 | Director | Informative Buy | 20.00K | $692.20K | |
| NVLNFNovelion Therapeutics | ― | ― | ― | $0.00 | ||
| SPHSSophiris Bio | ― | ― | ― | $0.00 | ||
| VRDNViridian Therapeutics | ― | Director | ― | ― |
You May Also Like
Joseph L. Turner insider profile FAQ
What stocks does Joseph L. Turner hold?
Joseph L. Turner holds: ARQT, CORT, VRDN, ALXA, KYTH, SPHS, NVLNF stocks.
What was Joseph L. Turner's most profitable transaction?
Joseph L. Turner’s most profitable transaction was an Informative Buy of CORT stock on March 14, 2013. The return on the trade was 87.00%.
What is Joseph L. Turner's role in Arcutis Biotherapeutics?
Joseph L. Turner's role in Arcutis Biotherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
